AI Needs Somewhere to Plug In: 7 Stocks That Have the Power
OpenAI, Anthropic and others are searching for power-ready data center sites, creating opportunities for companies helping AI overcome its biggest infrastructure constraint.
Small Biotech Name Hits Radar With Promising Hair Loss Play
As higher interest rates drive two-tiered market action, I’m watching this name.
How to Trade This Cash-Rich Biopharma Name
This weekend’s covered call idea is around a cash-rich biopharma concern that is expecting a key FDA approval to close out 2026.
Bearish Bets: 3 Stocks to Short on Textbook Downtrends
Here’s how we’d play these names with bearish charts.
2 Unloved Stocks Outperforming the Market — And Their Customers
These under-the radar names are posting returns that blow away those of their better-known customers.
Cathie Wood’s Firm Makes $16 Million Rocket Lab Decision
We sold some of our position in the aerospace firm alongside ARK Invest.
Citigroup Turns to 2 Promising Biotech Stocks
Citigroup initiated coverage on a pair of names with new buy ratings.
Doug Kass: Now’s Best Time Ever for Pot
News of a ‘stay’ in the cannabis hearing has created an exceptional entry point.
